Clinical Trials Browser

Gastric Adenocarcinoma × Immunotherapy, Adoptive × 1 year × Clear all

NCT07103668 2025-10-23

A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients

Phase 3 Recruiting

Gastrointestinal

Gastric Adenocarcinoma